165
Pengikut
1
Paparan
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
71.350 -
+4.350
(+6.49%)
Jarak
66.900 - 72.000
(7.62%)
Buka
67.000
Tutup Terdahulu
67.000
Harga Beli
71.250
Beli Purata
('000)
27
Jual Beli
71.400
Purata Jual
('000)
5
Purata
('000)
7,254.2
Nilai
510,386,362
Catatan
-
Harga tertunda. Dikemas kini pada 02 Apr 2026 16:08.
Data dikuasakan oleh
Lihat Semua Acara
165
Loading Chart...
Please login to view stock data and analysis
